Wuhan Dazhong Dental Medical Co Ltd

Wuhan Dazhong Dental Medical Co Ltd maintains a strong liquidity position, with cash and equivalents of CNY 251.5 million, representing 78.5% of total assets. The company's enterprise value to revenue ratio of 1.23 suggests a conservative valuation relative to its revenue of CNY 371.6 million. The debt-to-equity ratio of 0.23 indicates a low leverage profile, with long-term debt of CNY 74.8 million compared to total equity of CNY 320.1 million. Profitability metrics show a return on invested capital (ROIC) of 18.2%, outperforming the cohort median of 12.5% for dental services providers. Operating cash flow of CNY 94.0 million supports a cash conversion cycle of 32 days, which is 15 days shorter than the industry median. The company's gross margin of 58.7% exceeds the sector average of 52.3%, reflecting efficient cost management in service delivery. The company operates in a single revenue segment, with all operations concentrated in domestic markets. This geographic concentration exposes the business to regulatory and macroeconomic risks in China, where 100% of revenue is generated. No material revenue diversification is evident across product lines or geographic regions. Revenue growth has been stable, with a 12.4% year-over-year increase in FY2024. The outlook for FY2025 projects a 9.8% revenue growth, driven by expansion in implantology and orthodontics services. The company's operating margin is expected to remain stable at 34.2%, supported by controlled overhead costs and pricing power in premium dental procedures. Risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company has not issued new shares in the past 12 months, and diluted shares outstanding remain unchanged at 49.4 million. No material regulatory or litigation risks were identified in recent filings. Recent events include the completion of a new clinic in Wuhan, which is expected to increase capacity by 20% in Q2 2025. The company also announced a partnership with a dental equipment supplier to enhance service offerings, though no financial terms were disclosed.